Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the united states

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 1, 2014, Pages 77-87

  Dorman, Susan E ^a   Belknap, Robert ^b,c   Graviss, Edward A ^d   Reves, Randall ^b,c   Schluger, Neil ^e   Weinfurter, Paul ^f   Wang, Yaping ^a   Cronin, Wendy ^g   Hirsch Moverman, Yael ^e   Teeter, Larry D ^d   Parker, Matthew ^b,c   Garrett, Denise O ^h   Daley, Charles L ^b,i  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER PUBLIC HEALTH   (United States)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^e Columbia University ^*  (United States)

^f WESTAT   (United States)

^g MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ DEPARTMENT OF MEDICINE   (United States)

Author keywords

False positive; QuantiFERON; Screening; T SPOT.TB

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS TEST KIT; OCCUPATIONAL HAZARD; PREDICTION; PRIORITY JOURNAL; REPEAT PROCEDURE; REPRODUCIBILITY; T SPOT TEST; TUBERCULIN TEST; UNITED STATES;

EID: 84891859082     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201302-0365OC     Document Type: Article

References (46)

1. American Thoracic Society, Centers for Disease Control and Prevention; endorsed by Council of Infectious Diseases Society of America and American Academy of Pediatrics. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-S247.
2. Jensen PA, Lambert LA, Iademarco MF, Ridzon R; Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54:1-141.
3. Menzies D. Interpretation of repeated tuberculin tests: boosting, conversion, and reversion. Am J Respir Crit Care Med 1999;159: 15-21.
4. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-184.
5. Larsen NM, Biddle CL, Sotir MJ, White N, Parrott P, Blumberg HM. Risk of tuberculin skin test conversion among health care workers: occupational versus community exposure and infection. Clin Infect Dis 2002;35:796-801.
6. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention. Updated guidelines for using interferon γ release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010;59:1-25.
7. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-354.
8. Pai M, Riley LW, Colford JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761-776.
9. Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, Small PM. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999;284:1520-1523.
10. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361: 1168-1173.
11. Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A. Comparative performance of tuberculin skin test, Quanti FERONTB-Gold In-Tube assay, and T-SPOT. TB test in contact investigations for tuberculosis. Chest 2009;135:1010-1018.
12. Torres Costa J, Silva R, Sá R, Cardoso MJ, Nienhaus A. Serial testing with the interferon-g release assay in Portuguese healthcare workers. Int Arch Occup Environ Health 2011;84:461-469.
13. Gandra S, Scott WS, Somaraju V, Wang H, Wilton S, Feigenbaum M. Questionable effectiveness of the Quanti FERON-TB Gold test (Cellestis) as a screening tool in healthcare workers. Infect Control Hosp Epidemiol 2010;31:1279-1285.
14. Ringshausen FC, Nienhaus A, Torres Costa J, Knoop H, Schlösser S, Schultze-Werninghaus G, Rohde G. Within-subject variability of Mycobacterium tuberculosis-specific γ interferon responses in German health care workers. Clin Vaccine Immunol 2011;18: 1176-1182.
15. Ringshausen FC, Nienhaus A, Schablon A, Schlösser S, Schultze-Werninghaus G, Rohde G. Predictors of persistently positive Mycobacterium tuberculosis-specific interferon-γ responses in the serial testing of health care workers. BMC Infect Dis 2010; 10:220.
16. Yoshiyama T, Harada N, Higuchi K, Nakajima Y, Ogata H. Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-γ assays. Epidemiol Infect 2009;137:1691-1698.
17. Slater ML, Welland G, Pai M, Parsonnet J, Banaei N. Challenges with Quanti FERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit Care Med 2013;188: 1005-1010.
18. Dorman S, Belknap R, Weinfurter P, Teeter L, Thomas J, Daley C. Evaluation of new interferon-γ release assays in the diagnosis of latent tuberculosis infection in US health care workers: baseline results [abstract]. Am J Respir Crit Care Med 2009;179: A1010.
19. Belknap R, Kelaher J, Wall K, Daley C, Schluger N, Reves R. Diagnosis of latent tuberculosis infection in US health care workers: reproducibility, repeatability and 6 month follow-up with interferon γ release assays [abstract]. Am J Respir Crit Care Med 2009;179: A4101.
20. Belknap R; Tuberculosis Epidemiologic Studies Consortium. Interferonγ release assays in the serial testing for latent tuberculosis infection in US healthcare workers [abstract]. Am J Respir Crit Care Med 2010; 181:A2263.
21. Belknap R, Parker M, Wang Y, Dorman S, Graviss E, Weinfurter P, Daley C, Reves R; TB Epidemiologic Studies Consortium. Rerunning Quanti FERON TB Gold In-Tube samples as a strategy for identifying false positive results [abstract]. Am J Respir Crit Care Med 2011;183:A1187.
22. Tuberculin Purified Protein Derivative (Mantoux) TUBERSOL package insert [accessed 2012 Sept 25]. Available from: https://www.vaccineshoppe.com/image. cfm?doc-id=5985&image-type=product-pdf
23. Daniello J, Zöllner I. [Experiences with the intracutaneous Mendel-Mantoux tuberculin test in routine screening in a public health office][article in German]. Gesundheitswesen 1997;59:519-522.
24. QuantiFERON-TB Gold Package Insert [accessed 2011 Sept 27]. Available from: http://www.cellestis.com/IRM/Content/pdf/QuantiFeron%20US%20VerJ-JULY2011- ttf.pdf
25. T-SPOT.TB package insert [accessed 2011 Sept 27]. Available from: http://www.oxfordimmunotec.com/USpageInsert
26. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
27. World Health Organization. Global tuberculosis control: WHO Report 2010. WHO/HTM/TB/2010.7 [accessed 2013 Dec 18]. Available from: http://www.who.int/tb/ publications/global-report/2010/en/index.html
28. Rafiza S, Rampal KG. Serial testing of Malaysian health care workers with Quanti FERON®-TB Gold In-Tube. Int J Tuberc Lung Dis 2012; 16:163-168.
29. Ringshausen FC, Schablon A, Nienhaus A. Interferon-g release assays for the tuberculosis serial testing of health care workers: a systematic review. J Occup Med Toxicol 2012;7:6.
30. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, Reingold AL, Colford JM Jr, Riley LW, Menzies D. Serial testing of health care workers for tuberculosis using interferon-g assay. Am J Respir Crit Care Med 2006;174:349-355.
31. Schablon A, Harling M, Diel R, Ringshausen FC, Torres Costa J, Nienhaus A. Serial testing with an interferon-γ release assay in German healthcare workers. GMS Krankenhaushyg Interdiszip 2010; 5:1-8.
32. Joshi M, Monson TP, Woods GL. Use of interferon-γ release assays in a health care worker screening program: experience from a tertiary care centre in the United States. Can Respir J 2012;19: 84-88.
33. Mancuso JD, Mazurek GH, Tribble D, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW. Discordance among commercially available diagnostics for latent tuberculosis infection. Am J Respir Crit Care Med 2012;185:427-434.
34. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-γ release assays for detecting active TB: a metaanalysis. Chest 2010;137:952-968.
35. Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, Ha NP, Graviss EA. Test variability of the Quanti FERON-TB Gold In-Tube assay in clinical practice. Am J Respir Crit Care Med 2013;187:206-211.
36. Whitworth WC, Hamilton LR, Goodwin DJ, Barrera C, West KB, Racster L, Daniels LJ, Chuke SO, Campbell BH, Bohanon J, et al. Withinsubject interlaboratory variability of Quanti FERON-TB Gold In-Tube tests. PLoS One 2012;7:e43790.
37. Doberne D, Gaur RL, Banaei N. Preanalytical delay reduces sensitivity of Quanti FERON-TB Gold In-Tube assay for detection of latent tuberculosis infection. J Clin Microbiol 2011;49: 3061-3064.
38. Zwerling A, Benedetti A, Cojocariu M, McIntosh F, Pietroangelo F, Behr MA, Schwartzman K, Menzies D, Pai M. Repeat IGRA testing in Canadian health care workers: conversions or unexplained variability? PLoS One 2013;8:e54748.
39. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immunebased diagnosis of tuberculosis. Lancet 2000;356:1099-1104.
40. Migration Policy Institute. US in focus: foreign-born health-care workers in the United States [accessed 2011 Oct 18]. Available from: http://www.migrationinformation.org/USFocus/display.cfm?ID=583
41. Vinton P, Mihrshahi S, Johnson P, Jenkin GA, Jolley D, Biggs BA. Comparison of Quanti FERON-TB Gold In-Tube test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol 2009;30:215-221.
42. Zwerling A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, Benedetti A, Dendukuri N, Menzies D, Pai M. TB screening in Canadian health care workers using interferon-g release assays. PLoS One 2012;7:e43014.
43. van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, Badri M, Zumla A, Sechi LA, Bateman ED, et al. Within-subject variability and boosting of T-cell interferon-γ responses after tuberculin skin testing. Am J Respir Crit Care Med 2009;180:49-58.
44. Sauzullo I, Massetti AP, Mengoni F, Rossi R, Lichtner M, Ajassa C, Vullo V, Mastroianni CM. Influence of previous tuberculin skin test on serial IFN-γ release assays. Tuberculosis (Edinb) 2011;91: 322-326.
45. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-γ assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One 2009;4: e8517.
46. Nienhaus A, Ringshausen FC, Costa JT, Schablon A, Tripodi D. IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers. Expert Rev Anti Infect Ther 2013; 11:37-48.